Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.

NCT05695781 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

740

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: BRM421 Ophthalmic Solution
DRUG: Vehicle

Sponsor

BRIM Biotechnology Inc.